|
"whang peng j"的相關文件
顯示項目 91-100 / 215 (共22頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2013 |
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/beta-Catenin Signaling and Apoptosis Induction
|
CJ, Yao;GM, Lai;CT, Yeh;MT, Lai;PH, Shih;WJ, Chao;Whang-Peng, J;SE, Chuang;TY, Lai |
| 國家衛生研究院 |
2012-10 |
Development and validation of an instrument for the measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective
|
Chang, HH;Chie, WC;Chin, YH;Hsu, CP;Liu, TW;Whang-Peng, J |
| 國家衛生研究院 |
2012-01 |
Long-term results of a randomized, observation-controlled, phase III trial of adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen, LT;Chen, MF;Li, LA;Lee, PH;Jeng, LB;Lin, DY;Wu, CC;Mok, KT;Chen, CL;Lee, WC;Chau, GY;Chen, YS;Lui, WY;Hsiao, CF;Whang-Peng, J;Chen, PJ |
| 國家衛生研究院 |
2011-12 |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'ang, HJ;Lin, YL;Wang, HP;Chiu, YF;Chang, MC;Hsu, CH;Tien, YW;Chen, JS;Hsieh, RK;Lin, PW;Shan, YS;Cheng, AL;Chang, JY;Whang-Peng, J;Hwang, TL;Chen, LT |
| 國家衛生研究院 |
2011-08-17 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, JS;Chao, Y;Hsieh, RK;Cheng, AL;Chen, PM;Chiou, TJ;Chao, TY;Yeh, KH;Chen, LT;Whang-Peng, J |
| 高雄醫學大學 |
2011 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.
|
趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. |
| 國家衛生研究院 |
2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma
|
Shiah, H;Chen, C;Lin, Y;Su, W;Winkler, R;Chang, J;Lin, P;Whang-Peng, J;Chen, L |
| 國家衛生研究院 |
2009-12 |
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent
|
Chen, LT;Shiah, HS;Chao, Y;Chang, JY;Cheng, LT;Whang-Peng, J |
| 國家衛生研究院 |
2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, HJ;Huang, CL;Wang, HP;Shiah, HS;Chang, MC;Jan, CM;Chen, JS;Tien, YW;Hwang, TL;Lin, JT;Cheng, AL;Whang-Peng, J;Chen, LT |
| 國立臺灣大學 |
2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. Cancer Chemother Pharmacol.
|
Chang, HJ; Huang, CL; Wang, HP; Shiah, HS; Chang, MC; Jan, CM; Chen, JS; Tien, YW; Hwang, TL; Lin, JT; Cheng, AL; Whang-Peng, J; Chen, LT. |
顯示項目 91-100 / 215 (共22頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
